Cullinan Therapeutics Statistics
NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
15.63-0.62 (-3.82%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cullinan Therapeutics by the numbers
Cullinan Therapeutics has a market capitalization of $960.6 million based on 61.46M shares outstanding. With trailing EPS of $-3.11, Cullinan Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.4% below its 50-day average and 1.4% above its 200-day average.
Average daily trading volume is 868.12K shares, or about $13.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CGEM valuation vs. peer median
| Metric | CGEM | Peer median | Difference |
|---|---|---|---|
| Market cap | $960.59M | $868.27M | +11% |
| Avg. volume | 868.12K | 895.49K | -3% |
Peer median across 8 companies: MGTX, ODTX, GLUE, SLBT, SANA, VOR, IMTX, DNA.
Valuation
- Market cap
- $960.59M
- EPS (TTM)
- $-3.11
- Shares outstanding
- 61.46M
Price and trading
- Previous close
- 16.25
- Open
- 15.95
- Day range
- 15.47 – 16.44
- 52-week range
- 5.85 – 23.19
- 52-week change
- +165.37%
- Beta
- —
- Volume
- 808.18K
- Average volume
- 868.12K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 960.59M
- Forward Pe
- -6.21
- Eps
- -3.11
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.19
- Week52 Low
- 5.85
- Avg Volume
- 868.12K
- Shares Outstanding
- 61.46M
- Ma50
- 19.39
- Ma200
- 15.42
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -32.60%
- Pct From52w Low
- 167.18%